Akintunde Tolu Jemiseye, M.S., PMP, CPENT, CEH, is a Senior IT Technologist and former Senior Software Test Engineer specializing in FDA-compliant automation, software validation, and system security for regulated medical technology. With years of hands-on experience developing automated functional testing frameworks and continuous integration pipelines for surgical navigation and robotic products at Medtronic, Akintunde works at the intersection of high-speed software engineering and strict medical regulatory standards. He holds a Master of Science in Computer Science from the University of Louisiana at Lafayette and maintains advanced certifications across project management and enterprise cybersecurity.
Surgical robotics and computer-assisted navigation systems represent the modern frontier of minimally invasive medicine. From spine procedures requiring sub-millimeter trajectory accuracy to complex soft-tissue surgeries, these platforms extend the capabilities of surgeons and improve patient outcomes. However, behind every successful surgical robot lies millions of lines of intricate code interfacing with complex hardware, real-time tracking sensors, and safety-critical controls.
As medtech software becomes more sophisticated, medical device manufacturers face a growing challenge: maintaining rapid innovation cycles while adhering to rigorous regulatory standards set by the U.S. Food and Drug Administration (FDA) and international bodies. Traditional, manual Verification and Validation (V&V) methodologies are increasingly becoming operational bottlenecks. Automating FDA-compliant software testing is no longer just a technical luxury but it is a strategic necessity for accelerating life-saving innovations to market safely.
Historically, software verification for Class II and Class III medical devices relied heavily on manual test execution. Test engineers manually stepped through complex user interface workflows, hardware response checks, and edge case error handling scenarios.
While manual validation served earlier generations of medical devices well, modern surgical systems evolve rapidly. Agile development practices, frequent cybersecurity patch requirements, and continuous feature enhancements mean software builds are updated constantly. Under manual testing paradigms:
Validation cycles stretch into months, delaying critical software updates and system launches.
Human error and test fatigue introduce consistency risks across thousands of repetitive execution steps.
Regression testing becomes cost-prohibitive, forcing teams to balance test scope against aggressive commercial timelines.
To maintain software quality without compromising development velocity, medtech organizations must transition from manual verification to risk-based, automated test frameworks.
Integration: Integrating automated testing into medical device development requires strict alignment with FDA regulations, including 21 CFR Part 820 (Quality System Regulation) and standards like IEC 62304 (Medical Device Software – Software Life Cycle Processes).
Unlike non-regulated commercial software where automated testing focuses solely on rapid deployment, medical device software automation must build regulatory compliance directly into the testing execution pipeline.
Regulatory frameworks demand total traceability from user needs and functional requirements down to the exact test cases that verify them. Modern automated frameworks link automated test scripts directly to requirements management tools (such as JAMA or Jira). Every execution automatically updates requirement verification statuses in real time.
Utilizing containerized systems and virtual machines (VMs) allows test suites to simulate hardware interfaces, optical tracking cameras, and robotic controllers under exact, repeatable conditions. This isolates software behavior, ensuring that test failures stem from code anomalies rather than environmental variables.
Automated test runners must produce tamper-evident, time-stamped execution logs, screenshots, and system outputs. When automated test scripts execute within continuous integration/continuous deployment (CI/CD) pipelines, they generate automated validation packages that satisfy internal Quality Assurance (QA) auditors and FDA submission requirements.
Automating software validation does not mean cutting corners; rather, it elevates the standard of software quality.
Deeper Test Coverage: Automated frameworks can execute thousands of edge-case scenarios such as unexpected network latency, hardware disconnects, or boundary-condition surgical inputs that would be impractical to test manually.
Immediate Feedback Loops: Developers receive instant automated feedback on software builds, catching defects during early development phases when remediation is least expensive and risky.
Cybersecurity Agility: As cybersecurity threats against hospital networks rise, surgical devices require timely software patches. Automated regression testing enables rapid re-validation and deployment of security updates without subjecting the entire software stack to months of manual re-testing.
The primary purpose of regulatory compliance is patient safety. By modernizing software testing practices through scalable, automated validation frameworks, medical device developers can eliminate testing backlogs, reduce time-to-market, and deliver high-performance surgical software with uncompromised quality. As surgical navigation and robotic platforms continue to integrate artificial intelligence and machine learning components, automated validation will serve as the indispensable foundation that keeps medical innovation moving forward safely, reliably, and efficiently.
MBTpg/MSM